DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Taxane
Taxane
Re-Visiting Hypersensitivity Reactions to Taxanes: a Comprehensive Review
BC Cancer Benefit Drug List September 2021
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
Filed by Cell Therapeutics, Inc. Pursuant to Rule 425 Under The
Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: from Discovery to Implementation
Exosomes and Breast Cancer Drug Resistance Xingli Dong1,2, Xupeng Bai 2,3,Jieni2,3,Haozhang 4,Weiduan5, Peter Graham2,3 Andyongli 2,3,6
W O 2 11/ 28571Al
Treatment of Taxane Acute Pain Syndrome (TAPS) in Cancer Patients Receiving Taxane-Based Chemotherapy—A Systematic Review
CTI Corporate Presentation
Section B Changed Classes/Guidelines Final
(12) Patent Application Publication (10) Pub. No.: US 2007/0209082 A1 Lih Et Al
Homoharringtonine: a Pharmacognosy Success Story by Dr
REVIEW Taxanes: Promising Anti-Cancer Drugs
Cancer Tissue Classification, Associated Therapeutic Implications and PDT As an Alternative TAMARISK K
Irinotecan Mitomycin
Taxane-Containing Chemotherapy Regimens for the Treatment of Early (Operable) Breast Cancer
Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
Method of Administering and Using VEGF Inhibitors for the Treatment of Human Cancer
Top View
Stembook 2018.Pdf
Taxane Acute Pain Syndrome (TAPS) in Patients Receiving Taxane-Based Chemotherapy for Breast Cancer—A Systematic Review
Combinations in Multimodality Treatments and Clinical Outcomes During Cancer (Review)
Combination Chemotherapy with Docetaxel, Vinorelbine and Estramustine Phosphate in Metastatic Androgen-Resistant Prostate Cancer: a Single Institution Experience
Defining Risks of Taxane Neuropathy: Insights from Randomized Clinical Trials
Prior Authorization Criteria for FHCP's Medical Pharmacy Formulary Abatacept (Orencia)
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
EMJ-5.2-2020-2.Pdf
Chemogenomic Screening Identifies the Hsp70 Co-Chaperone HDJ2 As
Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation
Review TOLL-LIKE RECEPTORS
Mechanisms of Taxane Resistance
Ovarian Cancer
Exisulind in Combination with Docetaxel Inhibits Growth and Metastasis of Human Lung Cancer and Prolongs Survival in Athymic Nude Rats with Orthotopic Lung Tumors1
Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
Computationally Predicting Clinical Drug Combination Efficacy With
Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response
Review of the Available Evidence on Taxanes (Paclitaxel and Docetaxel) for Breast Cancer
Pharmaceutical Technology at the Service of Targeted Drug Delivery
Chemogenomic Screening Identifies the Hsp70 Co-Chaperone DNAJA1
Taxane-Induced Peripheral Neurotoxicity
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Does Gender Matter?
Arylquinoline and Analog Compounds and Use Thereof to Treat Cancer David S
Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products
Outcome of Combination Chemotherapy with Docetaxel
NIH Public Access Author Manuscript J Nat Prod
STING Promotes Breast Cancer Cell Survival by an Inflammatory-Independent
Opening Brief on the Merits on an Expedited Basis, Within One Week of Its Notice of Appeal
A Phase I and Pharmacokinetic Study of Exisulind and Docetaxel in Patients with Advanced Solid Tumors
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Antiproliferative Mechanism of Action of the Novel Taxane Cabazitaxel As Compared with the Parent Compound Docetaxel in MCF7 Breast Cancer Cells
Taxanes in the Treatment of Breast Cancer: Have We Better Defined Their Role in Older Patients? a Position Paper from a SIOG Task Force ⇑ L
WO 2016/196373 A2 8 December 2016 (08.12.2016) P O P C T
DRUG NAME: Paclitaxel
And Taxane-Pretreated Metastatic Breast Cancer
Immune-Based Mechanisms of Cytotoxic Chemotherapy: Implications for the Design of Novel and Rationale-Based Combined Treatments Against Cancer
List Item Withdrawal Assessment Report for Tekinex (PDF/558.5
Photochemical & Photobiological Sciences
Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
Prescribing Outlook New Medicines 2013
Overview of Dual-Acting Drug Methotrexate in Different
Filed by Cell Therapeutics, Inc. Pursuant to Rule 425 Under The
Photodynamic Diagnosis and Therapy for Peritoneal Carcinomatosis: Emerging Perspectives
Natural Product and Natural Product Derived Drugs in Clinical Trials
Drug Induced Onycholysis
Peripheral Neuropathy from Taxane-Containing Treatment for Advanced Nonsmall Cell Lung Cancer
(12) United States Patent (10) Patent No.: US 6,436,913 B1 Asp (45) Date of Patent: Aug